Skip to main content
. 2014 May 3;6:451–467. doi: 10.2147/IJWH.S38603

Table 1.

Summary of changes in BMD among amenorrheic athletes who gained weight and/or resumed menses

Reference Participants
Duration of follow-up Results
Sample Age (years) BMI (kg/m2) Change in body weight or BMI Resumption of menses Change in BMD
Case reports
Zanker et al83 Triathlete with primary amenorrhea 24.8 16.3 12 years +8.1 kg over 3 years N/A; OCs LS: +0.8% over 3 years
Hip: +16.9% over 3 years
Fredericson and Kent82 Distance runner with primary amenorrhea 22.9 15.8 8 years +16.9 kg OCs for 5 years followed by regular menstrual cycles for 3 years LS: +25.5%
Hip:+19.5%
Mallinson et al84 Two female athletes with secondary amenorrhea 19 20.4 12 months +4.2 kg 74 days into intervention LS: +0.8%
FN: −4.3%
Hip: −2.0%
24 19.7 +2.8 kg 23 and 144 days into intervention LS: +2.0%
FN:+1.4%
Hip:+1.9%
Follow-up studies
Drinkwater et al86 7 AA 26.7±2.l** 19.9 15 months +1.9 kg 4.7 months after baseline LS: +6.3%
7 EA 26.9±2.5** 20.6 −0.2 kg N/A LS: −0.3%
Jonnavithula et al87 5 AA 20.4±5.7* NR 2 years +5.4 kg Resumed, n=3 LS: + 13.3%
12 EA 23.5±5.l* NR −0.2 kg N/A LS: +3.2%
Keen and Drinkwater85 11 O/A 30.3+1.8** 19.1±0.5** 6–10 years 1.1 kg Resumed, n=6
OCs, n=4
Amen, n=1
No change relative to R/R group; BMD remained significantly below R/R group and R/O/A group for LS and FN, respectively
9 R/O/A 31.4±1.7** 20.3±0.6** +0.5 kg R, n=6
OCs, n=3
No change relative to R/R group
9 R/R 31.0+.1.1** 20.1±0.4** +4.6 kg N/A N/A
Warren et al88 10 AA NR NR 2 years NR Resumed, n=3 LS: +12.0%
17 EA NR NR NR N/A LS: +2.3%
Hind et al89 12 AA 22.0±3.6* 18.1±1.0* 5 years +1.8 kg/m2 Resumed; n=10 LS Z-score: ↑ from −1.5 to −0.9
Hip Z-score: ↑ from 0.3 to 0.6
6 EA 27.4±3.3* 19.0+1.2* +0.8 kg/m2 N/A LS Z-score: ↑ from −0.1 to 0.2
Hip Z-score: no change from 0.7

Notes:

*

mean±SD;

**

mean±SE.

Abbreviations: BMD, bone mineral density; OCs, oral contraceptives; LS, lumbar spine; FN, femoral neck; AA, amenorrheic athlete; EA, eumenorrheic athlete; O/A, had always been and were currently oligomenorrheic or amenorrheic; R/O/A, regularly menstruating with episodes of amenorrhea or oligomenorrhea; R/R, had always menstruated regularly; R, regularly menstruating at baseline and remained regularly menstruating during follow-up; Amen, amenorrheic at baseline and remained amenorrheic during follow-up; N/A, not applicable; NR, not reported.